Silver-Coated vs Standard Catheter for UTI Prevention

TriHealth

Status

Completed

Conditions

UTI

Treatments

Device: 2-Way Foley Urethral Urinary Catheter

Study type

Interventional

Funder types

Other

Identifiers

NCT05408533

22-004

Details and patient eligibility

About

Primary Aim: To determine whether silver-coated transurethral catheter decreases the incidence of culture-confirmed urinary tract infection for women with catheter-managed urinary retention after pelvic reconstructive surgery

Secondary Aims:

To assess difference in bacterial uropathogens isolated in urine cultures Adverse symptoms possibly caused by silver-coated catheter

Enrollment

310 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients who undergo major or minor pelvic organ prolapse surgery of any compartment, or urinary incontinence surgery that are diagnosed with POUR via failed retrograde voiding trial and require an indwelling transurethral catheter upon hospital discharge. Sacral neuromodulation procedures and intradetrusor onabotulinumtoxinA (Botox) injections are excluded.

Exclusion criteria

Unwilling or unable to participate in the study.
Unwilling or unable to do a catheter self-removal at home.
Inability to understand English.
Pregnant women
Patient personal history of urogenital anomaly, neurogenic bladder, use of chronic self-intermittent catheterization or suprapubic tubes, ureteral stents or other genitourinary indwelling devices, immunosuppressed state or chronic use of steroids.
Currently (prior 3 months) undergoing medical management for recurrent UTI or interstitial cystitis
Active urinary tract infection.
Intraoperative bladder injury or cystotomy
Physical or mental impairment that would affect the subject's ability to perceive urinary tract infection symptoms
Reported allergy to silver metal